In agreement, using a proliferation assay, we determined that SERBP1 partial knockdown makes U251 and U343 GBM cells more sensitive to the PARP inhibitor PJ34 – Figure 4—figure supplement 1. The gene discussed is PARP1; the disease is glioblastoma.